“Draw a clinical protocol amendment approval workflow with quality review, corrections loop, ethics review for subject-risk changes, medical monitor review, regulatory filing decision, approved version release, site training, and effective date.”
図の背後にある意思決定を読み解く。
Quality review catches incomplete amendment packages.
Subject-risk changes receive IRB or ethics review.
Medical monitor acceptance remains required after ethics review.
A regulatory filing is conditional on the amendment.
Sites are trained only after the approved version is released.
This is a generic control-flow example for clinical research. Actual ethics and regulatory requirements depend on jurisdiction, protocol, sponsor, and study phase.
よくある質問
When is ethics review needed?
It is generally needed when changes affect subjects, consent, risk, or procedures, subject to local requirements.
Why train sites after release?
Training must use the final approved amendment and creates a record of readiness.
Does every amendment require a regulatory filing?
No. Filing obligations depend on the change and the jurisdiction.